marihuana monee - Lester Grinspoon, M.D., Associate Professor of Psychiatry (Emeritus) at Harvard Medical School "...We know that people smoke marijuana not because they are driven by uncontrollable "Reefer Madness" craving, as some propaganda would lead us to believe, but because they have learned its value from experience. Yet almost all of the research, writing, political activity, and legislation devoted to marijuana has been concerned only with the question of whether it is harmful and how much harm it does. The only exception is the growing medical marijuana movement, but as encouraging as that movement is, it represents only one category of marijuana use. The rest are sometimes grouped under the general heading of "recreational", but that is hardly an adequate description of, say, marijuana's capacity to catalyze ideas and insights, heighten the appreciation of music and art, or deepen emotional and sexual intimacy. These kinds of marijuana experiences, which I like to call "enhancement", are often misunderstood and under-appreciated -- not only by non-users, but even by some users, especially young people who are interested mainly in promoting sociability and fun. Most of marijuana's powers of enhancement are not as immediately available as its capacity to lift mood or improve appetite and the taste of food. Some learning may be required, and one way to learn is through other people's experience. Some colleagues and I hope to promote this kind of learning by assembling an anthology of accounts of cannabis enhancement experiences..." from: http://www.marijuana-uses.com . 041211 ... monee .. - From the 2004 edition of Substance Abuse, a Comprehensive Textbook, Edited by Joyce Lowinson and Published by Lippincott Williams and Wilkins Chapter 17 Marihuana Lester Grinspoon, James B. Bakalar and Ethan Russo "...The present generation of young people cannot remember when marihuana was an exotic weed with an aura of mythical power and mysterious danger. Although still illegal, it has become a commonplace part of the American social scene, used regularly by millions and occasionally used by millions more. A realistic view of this drug is now both more important and easier to achieve... Drug preparations from the hemp plant vary widely in quality and potency depending on the type (there are possibly three species or, alternatively, various ecotypes of a single species), climate, soil, cultivation, and method of preparation. When the cultivated plant is fully ripe, a sticky, golden yellow resin with a minty fragrance covers its flower clusters and top leaves. The plant’s resin contains the active substances, cannabinoids and essential oil terpenoids, which are produced by the plant in glandular trichomes (7). Preparations of the drug come in three grades, identified by Indian names. The cheapest and least potent, called bhang, is derived from the cut tops of uncultivated plants and has a low resin content. Much of the marihuana smoked in the United States, particularly a few years ago, was of this grade. Ganja is obtained from the unfertilized flowering tops and leaves of carefully selected, cultivated plants, and it has a higher quality and quantity of resin. The third and highest grade of the drug, called charas in India, is largely made from the resin itself, obtained from the tops of mature plants; only this version of the drug is properly called hashish. Hashish can also be smoked, eaten, or drunk. Recently, more potent and more expensive marihuana from Thailand, Hawaii, British Columbia and California has become available in this country. Some California growers have been successful in cultivating an unpollinated plant by the early weeding out of male plants; the product is the much sought-after sinsemilla. Such new breeding and cultivation techniques have raised the tetrahydrocannabinol content of marihuana smoked in the United States over the last 20 years; while there have been some extravagant claims about the size of this increment, most authorities believe it has been modest (8, 9). On average, street cannabis is not much more potent than it was in the 1960s. The chemistry of the cannabis drugs is extremely complex and not completely understood. In the 1940s it was determined that the active constituents are various isomers of tetrahydrocannabinol. The delta-9 form (hereafter called THC) has been synthesized and is believed to be the primary active component of marihuana. However, the drug’s effects probably involve other components such as cannabidiol, other cannabinoids and terpenoids (7), and also depend on the form in which it is taken. There are more than 60 cannabinoids in marihuana and a number of them are thought to be biologically active. This activity is apparently mediated by the recently discovered receptors in the brain and elsewhere in the body which are stimulated by THC (10). This exciting discovery implied that the body produces its own version of cannabinoids for one or more useful purposes. The first of these cannabinoid-like neurotransmitters was identified in 1992 and named anandamide (ananda is the Sanskrit word for bliss) (11). Cannabinoid receptor sites occur not only in the lower brain but also in the cerebral cortex and the hippocampus... the effects from smoking last from 2 to 4 hours, the effects from ingestion 5 to 12 hours. For a new user, the initial anxiety that sometimes occurs is alleviated if supportive friends are present. The intoxication heightens sensitivity to external stimuli, reveals details that would ordinarily be overlooked, makes colors seem brighter and richer, and brings out values in works of art that previously had little or no meaning to the viewer. It is as though the cannabis-intoxicated adult perceives the world with some of the newness, wonder, curiosity, and excitement of a child; the person’s world becomes more interesting and details that had been taken for granted now attract more attention. The high also enhances the appreciation of music; many jazz and rock musicians have said that they perform better under the influence of marihuana, but this effect has not been objectively confirmed. The sense of time is distorted: 10 minutes may seem like an hour. Curiously, there is often a splitting of consciousness, so that the smoker, while experiencing the high, is at the same time an objective observer of his or her own intoxication. The person may, for example, be afflicted with paranoid thoughts yet at the same time be reasonably objective about them: laughing or scoffing at them and, in a sense, enjoying them. The ability to retain a degree of objectivity may explain the fact that many experienced users of marihuana manage to behave in a perfectly sober fashion in public even when they are highly intoxicated. Although the intoxication varies with psychological set and social setting, the most common response is a calm, mildly euphoric state in which time slows and sensitivity to sights, sounds, and touch is enhanced. The smoker may feel exhilaration or hilarity and notice a rapid flow of ideas with a reduction in short-term memory. Images sometimes appear before closed eyes; visual perception and body image may undergo subtle changes... Marihuana is sometimes referred to as a hallucinogen. Many of the phenomena associated with lysergic acid diethylamide (LSD) and LSD-type substances can be produced by cannabis, but only at very high dosage. As with LSD, the experience often has a wave-like aspect. Other phenomena commonly associated with both types of drugs are distorted perception of various parts of the body, spatial and temporal distortion, depersonalization, increased sensitivity to sound, synesthesia, heightened suggestibility, and a sense of thinking more clearly and having deeper awareness of the meaning of things. Anxiety and paranoid reactions are also sometimes seen as consequences of either drug. However, the agonizingly nightmarish reactions that even the experienced LSD user may endure are quite rare among experienced marihuana smokers, not simply because they are using a far less potent drug, but also because they have much closer and continuing control over the extent and type of reaction they wish to induce. Furthermore, cannabis has a tendency to produce sedation, whereas LSD and LSD-type drugs may induce long periods of wakefulness and even restlessness. Unlike LSD, marihuana does not dilate the pupils or materially heighten blood pressure, reflexes, and body temperature. (On the other hand, it does increase the pulse rate, while lowering blood pressure.) Tolerance develops rapidly with LSD-type drugs but little with cannabis. Finally, marihuana lacks the potent consciousness-altering qualities of LSD, peyote, mescaline, psilocybin, and other hallucinogens; it is questionable whether in doses ordinarily used in this country it can produce true hallucinations. These differences, particularly the last, cast considerable doubt on marihuana’s credentials for inclusion among the hallucinogens... One of the first questions asked about any drug is whether it is addictive or produces dependence. This question is hard to answer because the terms addiction and dependence have no agreed-upon definitions. Two recognized signs of addiction are tolerance and withdrawal symptoms; these are rarely a serious problem for marihuana users. In the early stages, they actually become more sensitive to the desired effects. After continued heavy use, some tolerance to both physiological and psychological effects develops, although it seems to vary considerably among individuals. Almost no one reports an urgent need to increase the dose to recapture the original sensation. What is called behavioral tolerance may be partly a matter of learning to compensate for the effects of high doses, and may explain why farm workers in some Third World countries are able to do heavy physical labor while smoking a great deal of marihuana... in a Jamaican study, heavy ganja users did not report abstinence symptoms when withdrawn from the drug... there is little evidence that the withdrawal reaction ordinarily presents serious problems to marihuana users or causes them to go on taking the drug. In a recent comprehensive review, cannabis withdrawal was seen as producing symptoms that were low-level to non-existent, with inconsistent onset and offset, with heterogeneous effects claimed with greatest support for transient agitation, appetite change and sleep disturbance (17). In sum, the concept of cannabis withdrawal was considered unproven. In a more important sense, dependence means an unhealthy and often unwanted preoccupation with a drug to the exclusion of most other things. People suffering from drug dependence find that they are constantly thinking about the drug, or intoxicated, or recovering from its effects. The habit impairs their mental and physical health and hurts their work, family life, and friendships. They often know that they are using too much and repeatedly make unsuccessful attempts to cut down or stop. These problems seem to afflict proportionately fewer marihuana smokers than users of alcohol, tobacco, heroin, or cocaine. Even heavy users in places like Jamaica and Costa Rica do not seem to be dependent in this damaging sense. Marihuana’s capacity to lead to psychological dependence is not as strong as that of either tobacco or alcohol. Two experts from the University of California, San Francisco and National Institute on Drug Abuse independently compared the dependency potential of cannabis, alcohol, nicotine, caffeine, cocaine and heroin (18, 19). Cannabis was considered by both to carry the lowest overall risk (see figure 1). It is often difficult to distinguish between drug use as a cause of problems and drug use as an effect; this is especially true in the case of marihuana. Most people who develop a dependency on marihuana would also be likely to develop other dependencies because of anxiety, depression, or feelings of inadequacy... The idea has persisted that in the long run smoking marihuana causes some sort of mental or emotional deterioration. In three major studies conducted in Jamaica, Costa Rica, and Greece, researchers have compared heavy long-term cannabis users with nonusers and found no evidence of intellectual or neurological damage, no changes in personality, and no loss of the will to work or participate in society (20-22). The Costa Rican study showed no difference between heavy users (seven or more marihuana cigarettes a day) and lighter users (six or fewer cigarettes a day). Experiments in the United States show no effects of fairly heavy marihuana use on learning, perception, or motivation over periods as long as a year (23-26)... Much attention has also been devoted to the idea that marihuana smoking leads to the use of opiates and other illicit drugs: the stepping stone hypothesis, now commonly referred to as the gateway hypothesis, which has been rejected after extensive study by the Institute of Medicine (28) and Canadian Senate (29). In this country, almost everyone who uses any other illicit drug has smoked marihuana first, just as almost everyone who smokes marihuana has drunk alcohol first. Anyone who uses any given drug is more likely to be interested in others, for some of the same reasons. People who use illicit drugs, in particular, are somewhat more likely to find themselves in company where other illicit drugs are available. None of this proves that using one drug leads to or causes the use of another. Most marihuana smokers do not use heroin or cocaine, just as most alcohol drinkers do not use marihuana. The metaphor of stepping stones suggests that if no one smoked marihuana it would be more difficult for anyone to develop an interest in opiates or cocaine. There is no convincing evidence for or against this. What is clear is that at many times and places marihuana has been used without these drugs, and that these drugs have been used without marihuana. Only the unsophisticated continue to believe that cannabis leads to violence and crime. Indeed, instead of inciting criminal behavior, cannabis may tend to suppress it. The intoxication induces a mild lethargy that is not conducive to any physical activity, let alone the commission of crimes. The release of inhibitions results in fantasy and verbal (rather than behavioral) expression. During the high, marihuana users may say and think things they would not ordinarily say and think, but they generally do not do things that are foreign to their nature. If they are not already criminals, they will not commit crimes under the influence of the drug... Many marihuana users report that the high enhances the enjoyment of sexual intercourse, and it has been an aid to tantric sexual meditation in India and Tibet since ancient times (30). This appears to be true in the same sense that the enjoyment of art and music is apparently enhanced. It is questionable, however, that the intoxication breaks down barriers to sexual activity that are not already broken... Does marihuana lead to physical and mental degeneracy? Reports from many investigators, particularly in Egypt and parts of the Orient, indicate that long-term users of the potent versions of cannabis are, indeed, typically passive, nonproductive, slothful, and totally lacking in ambition. This suggests that chronic use of the drug in its stronger forms may have debilitating effects, as prolonged heavy drinking does. There is a far more likely explanation, however. Many of those who take up cannabis in these countries are poverty stricken, hungry, sick, hopeless, or defeated, seeking through this inexpensive drug to soften the impact of an otherwise unbearable reality. This also applies to many of the “potheads” in the United States. In most situations one cannot be certain which came first: the drug, on the one hand, or the depression, anxiety, feelings of inadequacy, or the seemingly intolerable life situation on the other. Numerous chronic use studies have failed to differentiate personality differences between cannabis users and non-users. There is a substantial body of evidence that moderate use of marihuana does not produce physical or mental deterioration. One of the earliest and most extensive studies of this question was an investigation conducted by the British Government in India in the 1890s. The investigating agency, called the Indian Hemp Drugs Commission, interviewed some 800 people—including cannabis users and dealers, physicians, superintendents of mental asylums, religious leaders, and a variety of other authorities—and in 1894 published a report of more than 3000 pages. It concluded that there was no evidence that moderate use of the cannabis drugs produced any disease or mental or moral damage or that it tended to lead to excess any more than did the moderate use of whiskey (31, 32). In the LaGuardia study in New York City, an examination of chronic users who had averaged about seven marihuana cigarettes a day (a comparatively high dosage) over a long period (the mean was eight years) showed that they had suffered no demonstrable mental or physical decline as a result of their use of the drug (33). The 1972 report of the National Commission on Marihuana and Drug Abuse (34), although it did much to demythologize cannabis, cautioned that, of people in the United States who used marihuana, 2% became heavy users and that these abusers were at risk, but it did not make clear exactly what risk was involved. Furthermore, since the publication of this report, several controlled studies of chronic heavy use have been completed that have failed to establish any pharmacologically induced harmfulness, including personality deterioration or the development of the so-called amotivational syndrome (21-26, 35-37). The most recent government sponsored review of cannabis, Marijuana and Medicine, conducted by the Institute of Medicine, while cautious in its summary statement, found little documentation for most of the alleged harmfulness of this substance... Of 41 first-break acute schizophrenic patients studied by Dr. Grinspoon at the Massachusetts Mental Health Center, it was possible to elicit a history of marihuana use in 6 (43). In 4 of the 6 it seemed quite improbable that the drug could have had any relation to the development of the acute psychosis, because the psychosis was so remote in time from the drug experience. Careful history taking and attention to details of the drug experiences and changing mental status in the remaining 2 patients failed either to implicate or exonerate marihuana as a precipitant in their psychoses... There is little support for the idea that cannabis contributes to the etiology of schizophrenia. And in one recently reported case, a 19-year-old schizophrenic woman was more successfully treated with cannabidiol (one of the cannabinoids in marihuana) than she had been with haloperidol (46)... Interestingly, cannabis may ameliorate certain symptoms of psychosis (50), including activation symptoms and subjective complaints of depression, anxiety, insomnia and pain. It is noteworthy that levels of anandamide are elevated in the brains of schizophrenics (51) Although there is little evidence for the existence of a cannabis psychosis, it seems clear that the drug may precipitate in susceptible people one of several types of mental dysfunction. The most serious and disturbing of these is the toxic psychosis. This is an acute state that resembles the delirium of a high fever. It is caused by the presence in the brain of toxic substances that interfere with a variety of cerebral functions. Generally speaking, as the toxins disappear, so do the symptoms of toxic psychosis. This type of reaction may be caused by any number of substances taken either as intended or inadvertent overdoses. The syndrome often includes clouding of consciousness, restlessness, confusion, bewilderment, disorientation, dreamlike thinking, apprehension, fear, illusions, and hallucinations. It generally requires a rather large ingested dose of cannabis to induce a toxic psychosis. Such a reaction is apparently much less likely to occur when cannabis is smoked, perhaps because not enough of the active substances can be absorbed sufficiently rapidly or possibly because the process of smoking modifies in some yet unknown way those cannabinoids that are most likely to precipitate this syndrome. Some marihuana users suffer what are usually short-lived, acute, anxiety states, sometimes with and sometimes without accompanying paranoid thoughts. The anxiety may reach such proportions as properly to be called panic. Such panic reactions, although uncommon, probably constitute the most frequent adverse reaction to the moderate use of smoked marihuana. During this reaction, the sufferer may believe that the various distortions of bodily perceptions mean that he or she is dying or is undergoing some great physical catastrophe, and similarly the individual may interpret the psychological distortions induced by the drug as an indication of his or her loss of sanity. Panic states may, albeit rarely, be so severe as to incapacitate, usually for a relatively short period of time. The anxiety that characterizes the acute panic reaction resembles an attenuated version of the frightening parts of an LSD or other psychedelic experience—the so-called “bad trip.” Some proponents of the use of LSD in psychotherapy have asserted that the induced altered state of consciousness involves a lifting of repression. Although the occurrence of a global undermining of repression is questionable, many effects of LSD do suggest important alterations in ego defenses. These alterations presumably make new percepts and insights available to the ego; some, particularly those most directly derived from primary process, may be quite threatening, especially if there is no comfortable and supportive setting to facilitate the integration of the new awareness into the ego organization. Thus, psychedelic experiences may be accompanied by a great deal of anxiety, particularly when the drugs are taken under poor conditions of set and setting; to a much lesser extent, the same can be said of cannabis. These reactions are self-limiting, and simple reassurance is the best method of treatment. Perhaps the main danger to the user is that she will be diagnosed as having a toxic psychosis. Users with this kind of reaction may be quite distressed, but they are not psychotic. The sine qua non of sanity, the ability to test reality, remains intact, and the panicked user is invariably able to relate the discomfort to the drug. There is no disorientation, nor are there true hallucinations. Sometimes this panic reaction is accompanied by paranoid ideation. The user may, for example, believe that the others in the room, especially if they are not well known, have some hostile intentions or that someone is going to inform on the user, often to the police, for smoking marihuana. Generally speaking, these paranoid ideas are not strongly held, and simple reassurance dispels them. Anxiety reactions and paranoid thoughts are much more likely in someone who is taking the drug for the first time or in an unpleasant or unfamiliar setting than in an experienced user who is comfortable with the surroundings and companions; the reaction is very rare where marihuana is a casually accepted part of the social scene. The likelihood varies directly with the dose and inversely with the user’s experience; thus, the most vulnerable person is the inexperienced user who inadvertently (often precisely because he or she lacks familiarity with the drug) takes a large dose that produces perceptual and somatic changes for which the user is unprepared... Rarely, but especially among new users of marihuana, there occurs an acute depressive reaction. It is generally rather mild and transient but may sometimes require psychiatric intervention. This type of reaction is most likely to occur in a user who has some degree of underlying depression; it is as though the drug allows the depression to be felt and experienced as such. Again, set and setting play an important part. Cannabis has been of benefit in mood stabilization in case reports from patients with bipolar disease (52). Most recent research on the health hazards of marihuana concerns its long-term effects on the body. The main physiological effects of cannabis are increased appetite, a faster heartbeat, and slight reddening of the conjunctiva. Although the increased heart rate could be a problem for people with cardiovascular disease, dangerous physical reactions to marihuana are almost unknown. No human being is known to have died of an overdose. By extrapolation from animal experiments, the ratio of lethal to effective (intoxicating) dose is estimated to be on the order of thousands to one. Studies have examined the brain, the immune system, the reproductive system, and the lungs. Suggestions of long-term damage come almost exclusively from animal experiments and other laboratory work. Observations of marihuana users and the Caribbean, Greek, and other studies reveal little disease or organic pathology associated with the drug (21, 22, 27, 53). For example, there are several reports of damaged brain cells and changes in brain-wave readings in monkeys smoking marihuana, but neurological and neuropsychological tests in Greece, Jamaica, and Costa Rica found no evidence of functional brain damage. A recent study of enrolled patients in the Compassionate Use Investigational New Drug Program in the USA also demonstrated no significant EEG or P300 changes (54). Damage to white blood cells has also been observed in the laboratory, but again, its practical importance is unclear. Whatever temporary changes marihuana may produce in the immune system, they have not been found to increase the danger of infectious disease or cancer. If there were significant damage, we might expect to find a higher rate of these diseases among young people beginning in the 1960s, when marihuana first became popular. There is no evidence of that. Recent studies in HIV (55) and in the Missoula Chronic Use Study (54) also failed to demonstrate deleterious effects on white blood cell or CD4 counts... A well-confirmed danger of long-term, heavy marihuana use is its effect on the lungs. Smoking narrows and inflames air passages and reduces breathing capacity; damage to bronchial cells has been observed in hashish smokers. The possible side effects include bronchitis, emphysema, and lung cancer. Interestingly, one study failed to demonstrate emphysematous degeneration in cannabis smokers over time (57). Marihuana smoke contains the same carcinogens as tobacco smoke, usually in somewhat higher concentrations, at least in cannabis supplied by NIDA. THC may actually interfere with a key biochemical step in carcinogenesis (58). Marihuana is also inhaled more deeply and held in the lungs longer, which increases the danger (59, 60). On the other hand, almost no one smokes 20 marihuana cigarettes a day. Marihuana of higher potency may reduce the danger of respiratory damage, because less smoking is required for the desired effect. There is now some experimental evidence demonstrating that high-potency THC cigarettes are smoked less vigorously than those of low potency; the user takes smaller and shorter puffs, inhaling less with each puff (61). Vaporization technology may also reduce risks (62)... It is hard to generalize about abuse or define specific treatments, because the problems associated with marihuana are so vague, and cause and effect so hard to determine. Marihuana smokers may be using the drug as a facet of adolescent exploration, to demonstrate rebelliousness, cope with anxiety, medicate themselves for early symptoms of mental illness, or most commonly, simply for pleasure... It is appropriate to consider psychotherapy for the frequent adolescent users of marihuana. The picture that emerges is “one of a troubled adolescent who is interpersonally alienated, emotionally withdrawn, and manifestly unhappy, and who expresses his or her maladjustment through undercontrolled, overtly antisocial behavior” (63). They are described as being “overreactive to minor frustrations, likely to think and associate to ideas in unusual ways, having brittle ego-defense systems, self-defeating, concerned about the adequacy of their bodily functioning, concerned about their adequacy as persons, prone to project their feelings and motives onto others, feeling cheated and victimized by life, and having fluctuating moods.” Obviously, psychotherapy is not inappropriate for individuals who exemplify this description. But it should be emphasized that this is not psychotherapy for marihuana abuse; it is therapy for the underlying psychopathology, one of whose symptoms is the abuse of cannabis. It is no more appropriate to see marihuana as the cause of the problem here than it is to see repetitive hand-washing as the cause of obsessive-compulsive disorder. The individual may be brought to psychiatric attention because of the hand-washing, but the therapy will address the underlying disorder. Becoming attached to cannabis is not so much a function of any inherent psychopharmacological property of the drug as it is emotionally driven by the underlying psychopathology. Success in curtailing cannabis use requires dealing with that pathology... Cannabis usage as a medicament is ancient, and has included indications for headache (64, 65), other types of pain (66), obstetrical and gynecological conditions (67), and psychiatric disorders (68, 69)... Although its use was already declining somewhat because of the introduction of synthetic hypnotics and analgesics, it remained in the United States Pharmacopoeia until 1941. The difficulties imposed on its use by the Marihuana Tax Act of 1937 as well as quality-control issues with uncertain supplies completed its medical demise, and, from that time on, physicians allowed themselves to become ignorant about the drug. The greatest advantage of cannabis as a medicine is its unusual safety. The ratio of lethal dose to effective dose is estimated on the basis of extrapolation from animal data to be about 20,000:1. Huge doses have been given to dogs without causing death, and there is no reliable evidence of death caused by cannabis in a human being. Cannabis also has the advantage of not disturbing any physiological functions or damaging any body organs when it is used in therapeutic doses. It produces little physical dependence or tolerance; there has never been any evidence that medical use of cannabis has led to habitual use as an intoxicant... Whole cannabis preparations have the disadvantages of instability, varying strength, and insolubility in water, which makes it difficult for the drug to enter the bloodstream from the digestive tract. Another problem is that marihuana contains so many ingredients with possible disadvantageous effects, including too high a degree of intoxication. This multitude of ingredients is also an opportunity, since it suggests the manufacture of different cannabinoids, synthetic or natural, with properties useful for particular purposes; some of these have now become available (66, 71). One which is presently legally available for the treatment of nausea and vomiting of cancer chemotherapy and the AIDS weight loss syndrome is dronabinol (Marinol®), a synthetic THC. While it is not as useful medicinally as whole smoked marihuana, it is legally available as a Schedule III drug. Smoking generates quicker and more predictable results because it raises THC concentration in the blood more easily and predictably to the needed level. Also, it may be hard for a nauseated patient in chemotherapy to take oral medicine. But many patients dislike smoking or cannot inhale (69). Alternative dosing approaches are discussed in several references (4, 66, 72-75). There are many anecdotal reports of marihuana smokers using the drug to reduce postsurgery pain, headache, migraine, menstrual cramps, phantom limbs, and other kinds of pain. It is the case that cannabis acts by mechanisms different from those of other analgesics through the endocannabinoid pain mechanisms (66), and that cannabis may be more effective than opiates in neuropathic pain states. Again, some new synthetic derivatives might prove useful as an analgesic, but this is not an immediate prospect. Because of reports that some people use less alcohol when they smoke marihuana, cannabis has been proposed as an adjunct to alcoholism treatment, but so far it has not been found useful (76-78). Most alcoholics neither want to substitute marihuana nor find it particularly helpful. But there might be some hope for use of marihuana in combination with disulfiram (Antabuse®)(76). Certainly a cannabis habit would be preferable to an alcohol habit for anyone who could not avoid dependence on a drug but was able to substitute one drug for another. About 20% of epileptic patients do not get much relief from conventional anticonvulsant medications. Cannabis has been explored as an alternative, at least since a case was reported in which marihuana smoking, together with the standard anticonvulsants phenobarbital and diphenylhydantoin (Dilantin®), was apparently necessary to control seizures in a young epileptic man (79) . Recent reports support the role of THC endocannabinoids in modulation of seizure threshold (80, 81). Cannabidiol also demonstrates anticonvulsant properties (7, 82). In one controlled study, cannabidiol in addition to prescribed anticonvulsants produced improvement in seven patients with grand mal seizures; three showed great ­improvement. Of eight patients who received a placebo instead, only one improved (85). Marihuana also reduces muscle spasm and tremors in some people who suffer from spastic disorders including multiple sclerosis (83, 84), cerebral palsy, and various other causes of hemiplegia and quadriplegia such as spinal cord injury or disease. Anecdotal reports of the use of cannabis for the relief of asthma abound. The antiasthmatic drugs that are available all have drawbacks—limited effectiveness or side effects. Because marihuana dilates the bronchi and reverses bronchial spasm, cannabis derivatives have been tested as anti-asthmatic drugs. Smoking marihuana would probably not be a good way to treat asthma because of chronic irritation of the bronchial tract by tars and other substances in marihuana smoke, so recent research has sought a better means of administration. THC in the form of an aerosol spray has been investigated extensively (59, 60). Other cannabinoids such as cannabinol and cannabidiol may be preferable to THC for this purpose. An interesting finding for future research is that cannabinoids may affect the bronchi by means of a different mechanism from that of the familiar antiasthmatic drugs. A promising new medical use for cannabis is treatment of glaucoma, the second leading cause of blindness in the United States. About a million Americans suffer from the form of glaucoma (wide angle) treatable with cannabis. Marihuana causes a dose-related, clinically significant drop in intraocular pressure that lasts several hours in both normal subjects and those with the abnormally high ocular tension produced by glaucoma. Oral or intravenous THC has the same effect, which seems to be specific to cannabis derivatives rather than simply a result of sedation. Cannabis does not cure the disease, but it can retard the progressive loss of sight when conventional medication fails and surgery is too dangerous (86). A recent comprehensive review supports the use of cannabinoids as antioxidant protective agents in the development of vascular retinopathy of glaucoma, a process independent of intraocular pressure... Smoking marihuana is a better way of titrating the dose than is the taking of an oral cannabinoid, and most patients seem to prefer it. Unfortunately, many patients, especially elderly ones, dislike the psychoactive effects of marihuana. Cannabis derivatives have several minor or speculative uses in the treatment of cancer, and one major use. As appetite stimulants, marihuana and THC may help to slow weight loss in cancer patients (88), as it has in AIDS patients (55). THC has also retarded the growth of tumor cells in some animal studies, but results are inconclusive, and another cannabis derivative, cannabidiol, seems to increase tumor growth (89). Possibly cannabinoids in combination with other drugs will turn out to have some use in preventing tumor growth. THC may promote apoptosis (programmed cell death) in some malignant cells (90). Limonene, a monoterpenoid component of cannabis resin has similar activity on breast tumor cells (91). But the most promising use of cannabis in cancer treatment is the prevention of nausea and vomiting in patients undergoing chemotherapy. About half of patients treated with anticancer drugs suffer from severe nausea and vomiting. In 25 to 30% of these cases, the commonly used antiemetics do not work (69). The nausea and vomiting are not only unpleasant but a threat to the effectiveness of the therapy. Retching can cause tears of the esophagus and rib fractures, prevent adequate nutrition, and lead to fluid loss. The antiemetics most commonly used in chemotherapy are prochlorperazine (Compazine®) and the newer ondansetron (Zofran®) and granisetron (Kytril®). The suggestion that cannabis might be useful arose in the early 1970s when some young patients receiving cancer chemotherapy found that marihuana smoking, which was, of course, illegal, reduced their nausea and vomiting. In one study of 56 patients who got no relief from standard antiemetic agents, 78% became symptom-free when they smoked marihuana (92). Previously unpublished state studies of smoked cannabis have demonstrated 70-100% relief of vomiting in some 748 chemotherapy patients (93). Several of the most urgent medical uses of cannabis are the treatment of the nausea and weight loss suffered by many AIDS patients. The nausea is often a symptom of the disease itself and a side effect of some of the medicines (particularly AZT). For many AIDS patients the most distressing and threatening symptom is cachexia. Marihuana will retard weight loss in most patients and even helps some regain weight (69)... Under federal and most state statutes, marihuana is listed as a Schedule I drug: high potential for abuse, no currently accepted medical use, and lacking in accepted safety for use under medical supervision. It cannot ordinarily be prescribed and may be used only under research conditions. Cannabis has recently been legalized for medical usage in Canada and Holland, while liberalization of laws is proceeding in the UK and elsewhere in Western Europe. The potential of cannabis as a medicine is yet to be realized, partly because of its reputation as an intoxicant, ignorance on the part of the medical establishment, and legal difficulties involved in doing the research (94). Recreational use of cannabis has affected the opinions of physicians about its medical potential in various ways. When marihuana was regarded as the drug of blacks, Mexican-Americans, and bohemians, doctors were ready to go along with the Bureau of Narcotics, ignore its medical uses, and urge prohibition. For years the National Organization for the Reform of Marijuana Laws and other groups have been petitioning the government to change this classification. Now that marihuana has become so popular among a broad section of the population, we have been more willing to investigate its therapeutic value. Recreational use now spurs medical interest instead of medical hostility. It is estimated that more than 70 million Americans have used cannabis and more than 10 million use it regularly. They use it not because they are driven by uncontrollable "Reefer Madness" craving, as some propaganda would lead us to believe, but because they have learned its value from experience. Yet almost all of the research, writing, political activity, and legislation devoted to marijuana has been concerned only with the question of whether it is harmful and how much harm it does. The only exception is the growing resurgence of interest in its usefulness as a medicine. But medicine represents only one category of marijuana use. The rest are sometimes grouped under the general heading of "recreational," but that is hardly an appropriate word to describe the many serious reasons for which people have learned to use cannabis. For example, many writers and artists have found that the cannabis high can be a catalyst to their creativity (95). Allen Ginsberg, writing while stoned, eloquently put it this way: "... the marijuana consciousness is one that, ever so gently, shifts the center of attention from habitual shallow purely verbal guidelines and repetitive secondhand ideological interpretations of experience to more direct, slower, absorbing, occasionally microscopically minute, engagement with sensing phenomena during the high moments or hours after one has smoked." (96) While many artists have learned to use cannabis as an aid to their creativity, many other users have discovered its capacity to catalyze the generation of ideas and insights, heighten the appreciation of music and art, or deepen emotional and sexual intimacy... This "enhancement" capacity is often under-appreciated -- not only by non-users, but even by some users, especially young people who are primarily interested in promoting sociability and fun. Most of marijuana's powers of enhancement are subtle and not as immediately available as its capacity to lift mood or improve appetite and the taste food. Many if not most people do not achieve a cannabis high during their first attempt or attempts because they have yet to learn to recognize the subtle changes in consciousness which comprise the marijuana experience. Similarly, the ability to make use of cannabis consciousness as an enhancer of various capacities appears to require both experience in achieving this state and learning how to make use of it. The potential dangers of marihuana when taken for pleasure and enhancement, and its possible usefulness as a medicine are historically and practically interrelated issues: historically, because the arguments used to justify public and official disapproval of recreational use have had a strong influence on opinions about its medical potential; practically, because the more evidence accumulates that marihuana is relatively safe even when used as an intoxicant, the clearer it becomes that the medical requirement of safety is satisfied. Most recent research is tentative, and initial enthusiasm for drugs is often disappointed after further investigation. But it is not as though cannabis were an entirely new agent with unknown properties. Studies done during the past 10 years have confirmed a centuries-old promise. With the relaxation of restrictions on research and the further chemical manipulation of cannabis derivatives, this promise will eventually be realized. The weight of past and contemporary evidence will probably prove cannabis to be valuable in a number of ways as a medicine. from: http://www.rxmarihuana.com/lowinson.htm . 041211 ... monee .. Marijuana and Medicine Assessing the Science Base Janet E. Joy, Stanley J. Watson, Jr., and John A. Benson, Jr., Editors Division of Neuroscience and Behavioral Health INSTITUTE OF MEDICINE NATIONAL ACADEMY PRESS Washington, D.C. http://books.nap.edu/html/marimed/ . 041211 ... monee sorry for my lack of proper quotation marks there) 041211 ... monee "...the illegality of cannabis is outrageous, an impediment to full utilization of a drug which helps produce the serenity and insight, sensitivity and fellowship so desperately needed in this increasingly mad and dangerous world..." - from: Mr. X By Carl Sagan "This account was written in 1969 for publication in Marihuana Reconsidered (1971). Sagan was in his mid-thirties at that time. He continued to use cannabis for the rest of his life." http://www.marijuana-uses.com/essays/002.html . 041211 ... monee "...Reports from many investigators, particularly in Egypt and parts of the Orient, indicate that long-term users of the potent versions of cannabis are, indeed, typically passive, nonproductive, slothful, and totally lacking in ambition..." i would just like to note that the common word is a lot of the marihuana being smoked/coming out of "egypt and parts of the orient" these days is said to be hash that has been laced with opium and other substances. it is not of the same grade of purity as bubblehash. 041211 ... monee cannabis and cancer: "...there exists no epidemiological or aggregate clinical data showing higher rates of lung cancer in people who smoke marijuana," Stroup said. He cited conclusions from a May 2000 John Hopkins University (Baltimore, MD) study that found no association between marijuana use and head, neck, or lung cancer in young adults. That study, which featured 164 participants, is the largest case-controlled study addressing marijuana use and cancer to date. Stroup noted that the BLF literature review did not cite the John Hopkins study, nor did it cite a 1997 study by Kaiser Permanente that observed no increase in deaths over a ten-year period among 14,000+ marijuana smokers when compared to non-smokers. Stroup did agree that marijuana smoke arguably carries some health risks. "Like tobacco smoke, marijuana smoke contains a number of irritants and carcinogens. However, most marijuana-only smokers likely do not inhale enough smoke to cause serious lung damage. In addition, many of these carcinogens may be reduced or eliminated by the use of marijuana vaporizers and other alternative smoking devices currently banned by the U.S. government." Stroup also noted that the chief psychoactive ingredient in marijuana, THC, is not carcinogenic and may actually offer protection against the development of some malignancies. A 1996 U.S. toxicology study found that rats administered THC over long periods of time failed to develop cancer and had fewer tumors than rats not given the agent. A follow up study by a Spanish research team in 2000 found that injections of synthetic THC eradicated malignant brain tumors - so-called gliomas - in one-third of treated rats, and prolonged life in another third by as much as six weeks..." http://www.norml.org/index.cfm?Group_ID=5460 .. "...Not only is the evidence linking cannabis smoking to cancer negative, but the largest human studies cited indicated that cannabis users had lower rates of cancer than nonusers. What's more, those who smoked both cannabis and tobacco had lower rates of lung cancer than those who smoked only tobacco -- a strong indication of chemo-prevention [4][12][13]. Even more, in 1975 researchers at the Medical College of Virginia found that cannabis showed powerful antitumor activity against both benign and malignant tumors (the government then banned all future cannabis/cancer research) [4]. In fact, the NEW ENGLISH DISPENSATORY of 1764 recommends boiled cannabis roots for the elimination of tumors [19]. Powerful evidence that cannabis not only does not cause cancer, but that it may prevent and even cure cancer..." http://www.conquestdesign.com/uncler/html/evidence.html . 041211 ... monee "...Marijuana, unlike tobacco and alcohol, does not appear to cause head, neck, or lung cancer, says a researcher from Johns Hopkins Medical School in Baltimore...Daniel E. Ford, MD, tried to sort out the evidence by the lifestyles -- including marijuana, tobacco, and alcohol use --...Ford tells WebMD that he wanted to find out whether the cancer patients were more likely to smoke marijuana or tobacco or to drink than were the healthy volunteers. According to Ford, he thought he would find an association between marijuana use and cancer, but "that the association would fall away when we corrected for tobacco use. That was not the case. The association was never there." And that surprised him because of the way marijuana is smoked: deep inhalations, with the smoke held in for effect. "It seemed natural that there would be some connection," he tells WebMD. Based on these findings, Ford says that cancer prevention efforts should "remain focused on tobacco and alcohol, two known carcinogens...We attempted to assess both lifetime and current use of substances," he says. Participants were also asked to differentiate between use of marijuana cigarettes, marijuana pipes, or consumed marijuana. Distinctions were also made between weekend and weekday use of marijuana, he says..."Daily marijuana use for a month or more was not associated with increased risk, nor was age at first use, depth of inhalation, or use of a pipe." Surprisingly, using marijuana was not associated with increased cancer risk, even among those who never used tobacco, he says..." http://my.webmd.com/content/article/23/1728_57309 .. - myths about cannabis "...The U.S. federal government has failed to make public its own 1994 study that undercuts its position that marijuana is carcinogenic - a $2 million study by the National Toxicology Program...the study "found absolutely no evidence of cancer." In fact, animals that received THC had fewer cancers... Researchers at the University of California (UCLA) School of Medicine have announced the results of an 8 - year study into the effects of long-term cannabis smoking on the lungs. In Volume 155 of the American Journal of Respiratory and Critical Care Medicine, Dr. D.P. Tashkin reported “Findings from the present long-term, follow-up study of heavy, habitual marijuana smokers argue against the concept that continuing heavy use of marijuana is a significant risk factor for the development of [chronic lung disease. ..Neither the continuing nor the intermittent marijuana smokers exhibited any significantly different rates of decline in [lung function]" as compared with those individuals who never smoked marijuana. Researchers added: "No differences were noted between even quite heavy marijuana smoking and non-smoking of marijuana..." http://www.alcp.org.nz/info/myths.htm . 041211 ... bb35 could only get through about 1/2 of this page. this is good stuff (pun about marihuana intended) but i needed to find out how to ...i guess blather. i can't believe i stumbled across these pages and am so relieved to see i'm not alone in oh so many ways. not only from topics of "i'm so stoned" (my google search which led me to you) but "me". oh my god. i am not alone. i am not alone. i am not alone. 060312 ... The Hermit My anti-depressant. Better than anything a doctor will prescribe. 060313 ... CT u know tho, it may be a good anti-depressant, but over long periods of time if u ever get left without it, u will be a very depressed person indeed as it actually causes depression, but if it works for you, smoke away, im high right now :) i guess thats why im on this site...... 070329 what's it to you? who go blather from